286 related articles for article (PubMed ID: 32885475)
61. Changes in masticatory function after injection of botulinum toxin type A to masticatory muscles.
Park HU; Kim BI; Kang SM; Kim ST; Choi JH; Ahn HJ
J Oral Rehabil; 2013 Dec; 40(12):916-22. PubMed ID: 24237358
[TBL] [Abstract][Full Text] [Related]
62. Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement.
Kurtoglu C; Gur OH; Kurkcu M; Sertdemir Y; Guler-Uysal F; Uysal H
J Oral Maxillofac Surg; 2008 Aug; 66(8):1644-51. PubMed ID: 18634953
[TBL] [Abstract][Full Text] [Related]
63. Bilateral treatment of the masseter with botulinum toxin: Consequences for mastication, muscle force and the mandibular condyle.
Liu ZZ; Rafferty KL; Wang DB; Owart B; Herring SW
J Oral Rehabil; 2023 Sep; 50(9):775-781. PubMed ID: 37178264
[TBL] [Abstract][Full Text] [Related]
64. The Use of Botulinum Toxin for the Treatment of Myofascial Pain in the Masticatory Muscles.
Laskin DM
Oral Maxillofac Surg Clin North Am; 2018 Aug; 30(3):287-289. PubMed ID: 30008341
[TBL] [Abstract][Full Text] [Related]
65. Botulinum toxin therapy for temporomandibular joint disorders: a systematic review of randomized controlled trials.
Chen YW; Chiu YW; Chen CY; Chuang SK
Int J Oral Maxillofac Surg; 2015 Aug; 44(8):1018-26. PubMed ID: 25920597
[TBL] [Abstract][Full Text] [Related]
66. Clinical Aspects of the Use of Botulinum Toxin Type A in the Treatment of Dysfunction of the Masticatory System.
Bogucki ZA; Kownacka M
Adv Clin Exp Med; 2016; 25(3):569-73. PubMed ID: 27629747
[TBL] [Abstract][Full Text] [Related]
67. Effect of botulinum toxin on quality of life of patients with chronic myofascial pain.
Miotto E; Salvatore Freitas KM; Mori AA; Valarelli FP; Gobbi de Oliveira RC; Oliveira RC
Pain Manag; 2021 Sep; 11(5):583-593. PubMed ID: 33980033
[No Abstract] [Full Text] [Related]
68. Muscle paralysis produced by botulinum toxin type A injection in treated torticollis patients compared with toxin naive individuals.
Sloop RR; Cole D; Patel MC
Mov Disord; 2001 Jan; 16(1):100-5. PubMed ID: 11215566
[TBL] [Abstract][Full Text] [Related]
69. Effect of Local Anesthetic Versus Botulinum Toxin-A Injections for Myofascial Pain Disorders: A Systematic Review and Meta-Analysis.
Ahmed S; Subramaniam S; Sidhu K; Khattab S; Singh D; Babineau J; Kumbhare DA
Clin J Pain; 2019 Apr; 35(4):353-367. PubMed ID: 30589660
[TBL] [Abstract][Full Text] [Related]
70. A pilot study of botulinum toxin A for male chronic pelvic pain syndrome.
Gottsch HP; Yang CC; Berger RE
Scand J Urol Nephrol; 2011 Feb; 45(1):72-6. PubMed ID: 21062115
[TBL] [Abstract][Full Text] [Related]
71. Morphologic and bony structural changes in the mandible after a unilateral injection of botulinum neurotoxin in adult rats.
Tsai CY; Huang RY; Lee CM; Hsiao WT; Yang LY
J Oral Maxillofac Surg; 2010 May; 68(5):1081-7. PubMed ID: 20189701
[TBL] [Abstract][Full Text] [Related]
72. A double-blind, controlled, randomized trial to evaluate the efficacy of botulinum toxin for the treatment of lumbar myofascial pain in humans.
De Andrés J; Adsuara VM; Palmisani S; Villanueva V; López-Alarcón MD
Reg Anesth Pain Med; 2010; 35(3):255-60. PubMed ID: 20921836
[TBL] [Abstract][Full Text] [Related]
73. Myofascial pain of the jaw muscles: comparison of short-term effectiveness of botulinum toxin injections and fascial manipulation technique.
Guarda-Nardini L; Stecco A; Stecco C; Masiero S; Manfredini D
Cranio; 2012 Apr; 30(2):95-102. PubMed ID: 22606852
[TBL] [Abstract][Full Text] [Related]
74. The use of botulinum toxin for the treatment of temporomandibular disorders: preliminary findings.
Freund B; Schwartz M; Symington JM
J Oral Maxillofac Surg; 1999 Aug; 57(8):916-20; discussion 920-1. PubMed ID: 10437718
[TBL] [Abstract][Full Text] [Related]
75. Localized myofascial pain responds better than referring myofascial pain to botulinum toxin injections.
Abboud WA; Hassin-Baer S; Joachim M; Givol N; Yahalom R
Int J Oral Maxillofac Surg; 2017 Nov; 46(11):1417-1423. PubMed ID: 28521968
[TBL] [Abstract][Full Text] [Related]
76. Recurrent TMJ Dislocation Managed with Botulinum Toxin Type A Injections in a Pediatric Patient.
Stark TR; Perez CV; Okeson JP
Pediatr Dent; 2015; 37(1):65-9. PubMed ID: 25685976
[TBL] [Abstract][Full Text] [Related]
77. Muscle fiber atrophy in leg muscles after botulinum toxin type A treatment of cervical dystonia.
Ansved T; Odergren T; Borg K
Neurology; 1997 May; 48(5):1440-2. PubMed ID: 9153487
[TBL] [Abstract][Full Text] [Related]
78. Effect of Preoperative Intramuscular Injection of Botulinum Toxin A on Pain and Mouth Opening After Surgical Intervention in Temporomandibular Joint Ankylosis Cases: A Controlled Clinical Trial.
Shandilya S; Mohanty S; Sharma P; Chaudhary Z; Kohli S; Kumar RD
J Oral Maxillofac Surg; 2020 Jun; 78(6):916-926. PubMed ID: 32171600
[TBL] [Abstract][Full Text] [Related]
79. Ultrasound-guided lateral pterygoid muscle botulinum toxin: an injection for recurrent temporomandibular joint dislocation in a brain injury patient.
Guo HJ; Wu CC; Li TC
Oral Maxillofac Surg; 2023 Jun; 27(2):365-371. PubMed ID: 35486190
[TBL] [Abstract][Full Text] [Related]
80. Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.
Utomo E; Groen J; Blok BF
Cochrane Database Syst Rev; 2014 May; 2014(5):CD004927. PubMed ID: 24859260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
